Mark L. is an experienced leader in clinical data management, currently serving as the Executive Director at Regeneron since May 2025. Previously, Mark L. held the same title at Daiichi Sankyo US from February 2022 to April 2025 and served as Vice President of Clinical Data Management at Mutare Lifesciences from February 2018 to January 2022. Mark L.'s career includes notable positions at Novartis, where responsibilities included Unit Head of Clinical Data Management for Translational Clinical Oncology and Group Head for Oncology Global Development, as well as Associate Director at Eisai US. Additional experience includes managerial roles at Sanofi, Endpoint, and Pfizer. Mark L. holds an MBA in Project Management from Lehigh University College of Business and a BSc (Hon) in Biochemistry and Human Biology from the University of Toronto - University of St. Michael's College.
This person is not in any teams
This person is not in any offices